A case of factor V inhibitor

作者: Lai-Lu Chong , Yuk-Cheung Wong

DOI: 10.1002/AJH.2830190410

关键词: GastroenterologyFactor VPartial thromboplastin timeFactor V DeficiencyImmunoglobulin GCyclophosphamideCoagulopathyAbnormal PlateletInternal medicineCoagulationImmunologyMedicineHematology

摘要: A 57-year-old married Chinese male without a family history of bleeding disorder was presented with severe hemorrhagic tendency and subsequently found to be suffering from an acquired inhibitor against coagulation factor V. The prolonged prothrombin time activated partial thromboplastin could not corrected by the addition normal plasma. Subnormal value V level noted accompanied abnormal platelet III availability test. With specific antisera staphylococcal protein A, characterized as IgG(lambda) antibody. laboratory data were after treating patient concentrate transfusion cyclophosphamide.

参考文章(10)
J Chediak, JB Ashenhurst, I Garlick, RK Desser, Successful management of bleeding in a patient with factor V inhibitor by platelet transfusions Blood. ,vol. 56, pp. 835- 841 ,(1980) , 10.1182/BLOOD.V56.5.835.835
Paul E. Hurtubise, Macie C. Coots, Albert F. Muhleman, Helen I. Glueck, Donald J. Jacob, A monoclonal IgG4 (lambda) with factor V inhibitory activity. Journal of Immunology. ,vol. 122, pp. 2119- 2121 ,(1979)
THOMAS A. LANE, Factor V Antibody and Disseminated Intravascular Coagulation Annals of Internal Medicine. ,vol. 89, pp. 182- 185 ,(1978) , 10.7326/0003-4819-89-2-182
E. B. Crowell, Observations on a factor-V inhibitor. British Journal of Haematology. ,vol. 29, pp. 397- 404 ,(1975) , 10.1111/J.1365-2141.1975.TB01837.X
Donald I. Feinstein, Samuel I. Rapaport, William G. McGehee, Mary Jane Patch, Factor V anticoagulants: clinical, biochemical, and immunological observations Journal of Clinical Investigation. ,vol. 49, pp. 1578- 1588 ,(1970) , 10.1172/JCI106375
CHARLES A. ONUORA, JOHN LINDENBAUM, HYMIE L. NOSSEL, Massive hemorrhage associated with circulating antibodies to factor V. The American Journal of the Medical Sciences. ,vol. 265, pp. 407- 417 ,(1973) , 10.1097/00000441-197305000-00008
K Bryning, J Leslie, Factor V inhibitor and bullous pemphigoid. BMJ. ,vol. 2, pp. 677- 678 ,(1977) , 10.1136/BMJ.2.6088.677
Walter H. Seegers, Che-Ming Teng, Eduardo Novoa, Preparation of bovine prethrombin 2: use of Acutin and activation with prothrombinase or Ecarin. Thrombosis Research. ,vol. 19, pp. 11- 20 ,(1980) , 10.1016/0049-3848(80)90399-0
DONALD I. FEINSTEIN, Factor V Inhibitor: Report of a Case, with Comments on a Possible Effect of Streptomycin Annals of Internal Medicine. ,vol. 78, pp. 385- 388 ,(1973) , 10.7326/0003-4819-78-3-385
R. M. Hardisty, R. A. Hutton, The Kaolin Clotting Time of Platelet-Rich Plasma: A Test of Platelet Factor-3 Availability British Journal of Haematology. ,vol. 11, pp. 258- 268 ,(1965) , 10.1111/J.1365-2141.1965.TB06586.X